• Akero

  • Vaisali Viswanathan Panyam
VP

Vaisali Viswanathan Panyam

Finance Manager, Clinical at Akero

Vaisali Viswanathan Panyam, CFA, currently serves as Finance Manager at Akero Therapeutics since May 2023. Previously, Vaisali held the position of Finance Manager, FP&A at Guardant Health (2022-2023) and worked as a Principal Financial Analyst at Western Digital from 2018 to 2022, where responsibilities included leading FP&A for $4 billion in channel sales revenue and advising senior executives. Earlier experience includes roles as Finance Project Manager at VMware (2017-2018), where Vaisali completed the centralization of planning processes, and as Senior Financial Analyst at Meraas (2012-2017), focusing on capital budgeting for a $400 million real estate portfolio. Vaisali began the career as Finance & Operations Staff at QFM Group (2010-2011). Academic qualifications include an MBA from Gies College of Business, University of Illinois Urbana-Champaign, and a Master’s in Finance, Accounting and Management from the University of Bradford.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Akero

1 followers

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH.